Who’s Prescribing? The Fragmented System Behind Behavioral Meds in Autism Care
In a decentralized care model, responsibility is shared—but rarely defined—leaving families to coordinate treatment on their own
Across the United States, a growing number of autistic children are prescribed medications to manage anxiety, irritability, attention challenges and sleep disturbances, but responsibility for those decisions is often diffuse. Estimates suggest that 50% to 70% of autistic children are prescribed at least one psychotropic medication, with many receiving multiple prescriptions over time. Yet there is no single system—or provider—consistently overseeing that care. Instead, medication decisions are frequently spread across pediatricians, child psychiatrists, neurologists and behavioral specialists, each operating within their own scope. The result is a fragmented approach in which the question is not only what is being prescribed, but who is ultimately accountable for those choices.
In practice, pediatricians often serve as the first point of contact and may initiate medications, particularly for attention-deficit/hyperactivity disorder, sleep issues or anxiety. Child psychiatrists are considered the most appropriate specialists to manage complex behavioral medication plans, including the use of FDA-approved drugs such as Risperidone and Aripiprazole for irritability in autism. However, access to child psychiatrists remains limited. The American Academy of Child and Adolescent Psychiatry has reported a national shortage, with some regions having fewer than 10 child psychiatrists per 100,000 children, leading to wait times that can stretch for months. In those gaps, prescribing responsibilities often fall back to general practitioners, who may have less specialized training in autism-specific pharmacology.
Neurologists may become involved when symptoms overlap with seizure disorders or other neurological conditions, while psychologists and behavioral therapists—though central to treatment planning—cannot prescribe medication. This division of roles can leave families navigating multiple providers without a clear lead decision-maker. Studies have shown that polypharmacy, or the use of multiple psychotropic medications, occurs in up to one-third of autistic children receiving medication, raising additional concerns about oversight, side effects and long-term outcomes. Without coordinated management, adjustments are often made in isolation, based on limited visibility into the full treatment picture.
The system’s structure places much of the coordination burden on caregivers, who must track medications, monitor side effects and communicate between providers. While best practice models call for a child psychiatrist to lead medication decisions in collaboration with pediatric and behavioral teams, such integrated care is not consistently available. As a result, medication use in autism frequently reflects a decentralized system shaped by access constraints rather than a unified standard of care.
As the prevalence of autism diagnoses continues to rise—currently estimated at 1 in 36 children in the United States, according to the Centers for Disease Control and Prevention—the number of families navigating this fragmented system is increasing. The broader issue extends beyond individual prescriptions to a structural question: in a system where multiple providers contribute to care, but none are clearly designated as the lead, accountability for outcomes remains unclear.
For families, this lack of clarity often translates into a confusing and inconsistent experience when seeking care. Parents report navigating long waitlists for specialists, receiving differing recommendations from multiple providers, and struggling to determine which guidance should take precedence. In many cases, they are left to piece together treatment plans on their own—researching medications, evaluating side effects, and coordinating communication between clinicians who may not regularly interact. Access to reliable, centralized resources can be limited, particularly outside major metropolitan areas, leaving families dependent on informal networks, online communities, or trial-and-error approaches. As a result, the challenge is not only managing a child’s care, but also navigating a system where responsibility is shared but not clearly defined, and where the burden of coordination often falls on those least equipped to carry it.